122 research outputs found

    Dear Reader

    Get PDF
    <p>Cell scratch test and Transwell were used to measure the migration abilities of HSVSMCs. NC = Negative control group, only control siRNA transfected; GAS5(-) = lncRNA-GAS5 knockdown group transfected with silence siRNA. <b>A:</b>Cell scratch test was used to measure the migration abilities of HSVSMCs. The results showed that the HSVSMCs have the best migration abilities in the first 24 hours. Values are mean±SE, N = 4. <b>B:</b> The migration abilities of HSVSMCs measured by Transwell. After transfected by lncRNA-GAS5 siRNA for 48 hours, the HSVSMCs were passage into the Transwell Inserts. Then 4 hours, 7 hours, 10 hours later, the migration HSVSMCs were photographed and counted, respectively. Knockdown of lncRNA-GAS5 expression promotes migration of HSVSMCs. Optical microscope images under 200x magnification. <b>C:</b> The migration abilities of HSVSMCs were reflected indirectly by the new migration cells counting with Transwell. Silencing of lncRNA-GAS5 expression increses migration ability of HSVSMCs. Values are mean±SE, N = 10; *, P<0.05.</p

    Correction to “Crystal Structures, Optical Properties, and Effective Mass Tensors of CH<sub>3</sub>NH<sub>3</sub>PbX<sub>3</sub> (X = I and Br) Phases Predicted from HSE06”

    No full text
    Correction to “Crystal Structures, Optical Properties, and Effective Mass Tensors of CH<sub>3</sub>NH<sub>3</sub>PbX<sub>3</sub> (X = I and Br) Phases Predicted from HSE06

    Region-specific multivariable-adjusted odds ratios (AOR) and lower and upper 95% confidence limits (LCL & UCL) per 10 µg/m<sup>3</sup> increment in PM for CVD complications, controlling for age, gender, race, education, income, smoking status, physical activeness, BMI (linear and quadratic terms), hypertension, hypercholesteraemia, diabetes, and year of interview.

    No full text
    <p>Region-specific multivariable-adjusted odds ratios (AOR) and lower and upper 95% confidence limits (LCL & UCL) per 10 µg/m<sup>3</sup> increment in PM for CVD complications, controlling for age, gender, race, education, income, smoking status, physical activeness, BMI (linear and quadratic terms), hypertension, hypercholesteraemia, diabetes, and year of interview.</p

    Crystal Structures, Optical Properties, and Effective Mass Tensors of CH<sub>3</sub>NH<sub>3</sub>PbX<sub>3</sub> (X = I and Br) Phases Predicted from HSE06

    No full text
    The crystal structures are successfully established for tetragonal and orthorhombic CH<sub>3</sub>NH<sub>3</sub>PbX<sub>3</sub> (X = I and Br). The equilibrium lattice parameters are computed by the DFT+D2 method, and the results are compared to experimental values. The band dispersions and electronic densities of states are calculated by HSE06, showing that their band gaps are in the range from 1.63 to 2.3 eV. Although the calculated dielectric functions of MAPbX<sub>3</sub> compounds are similar to other semiconductors, the absorption spectra of their bulk crystals are drifted away from visible light spectrum. The effective mass tensors of holes and electrons are also evaluated in three principal directions at the Γ point. The anisotropies in the effective masses of the hole and electron are illustrated for two orthorhombic phases

    Multivariable-adjusted odds ratios (AOR) and lower and upper 95% confidence limits (LCL & UCL) for CVD complications from PM<sub>2.5</sub>-fitted models —assessed with samples from the 2007 and 2009 Behavioral Risk Factor Surveillance System.

    No full text
    <p>Both regionally and non-regionally adjusted results were presented, with the former graphically displayed. BMI and (BMI-squared)/100 were included as continuous variables. PM<sub>2.5</sub>-related effects were associated with 10 µg/m<sup>3</sup> increment in yearly median levels.</p

    Correction to “Crystal Structures, Optical Properties, and Effective Mass Tensors of CH<sub>3</sub>NH<sub>3</sub>PbX<sub>3</sub> (X = I and Br) Phases Predicted from HSE06”

    No full text
    Correction to “Crystal Structures, Optical Properties, and Effective Mass Tensors of CH<sub>3</sub>NH<sub>3</sub>PbX<sub>3</sub> (X = I and Br) Phases Predicted from HSE06

    Distributions of PM<sub>10</sub> and PM<sub>2.5</sub>,1999–2005, surveillance-oriented sites from contiguous U.S. region.

    No full text
    a<p>Following the promulgation of the National Ambient Air Quality Standard for PM<sub>2.5</sub> in 1997, routine collection of PM<sub>2.5</sub> was implemented in 1999. No attempt was made to convert PM<sub>10</sub> concentrations to PM<sub>2.5</sub>, which requires a scaling factor based on a presumptive proportion of PM<sub>2.5</sub> in the PM<sub>10</sub> mass.</p>b<p>Sites describe unique sampling points indicated by longitude/latitude. Those providing no geodetic datum information were not included.</p>c<p>While PM was typically measured at a frequency of every six days or higher, many sites took daily sampling.</p

    Effective Masses and Electronic and Optical Properties of Nontoxic MASnX<sub>3</sub> (X = Cl, Br, and I) Perovskite Structures as Solar Cell Absorber: A Theoretical Study Using HSE06

    No full text
    We calculated the effective masses and electronic and optical properties of CH<sub>3</sub>NH<sub>3</sub>SnX<sub>3</sub> (X = Cl, Br, I) perovskites as a solar cell absorber using the HSE06 hybrid functional. The computed band gaps are direct at the Γ point, ranging from 1.67 to 3.0 eV. The effective masses of carriers and the band gaps decrease from chlorine to iodine. Moreover, their hole masses are comparable to those of CH<sub>3</sub>NH<sub>3</sub>PbX<sub>3</sub> (X = Br and I) phases. The optical dielectric constant does not decrease monotonically when going from X = Cl to Br to I for CH<sub>3</sub>NH<sub>3</sub>SnX<sub>3</sub> perovskites. Under a small isotropic compressive stress, the photon absorption efficiency of CH<sub>3</sub>NH<sub>3</sub>SnX<sub>3</sub> perovskites is slightly improved due to the reduction of the fundamental band gap

    Estimated background PM<sub>10</sub> and PM<sub>2.5</sub> concentrations (µg/m<sup>3</sup>) across contiguous U.S. counties.

    No full text
    <p>A—PM<sub>10</sub> yearly median concentrations (averaging 1999–2005), assessed with ordinary kriging, exponential covariance, lag distance = 125 km, nugget = 0.037, range = 1,538 km, partial sill = 0.083; B—PM<sub>2.5</sub> yearly median concentrations (averaging 1999–2005), assessed with ordinary kriging, spherical covariance, lag distance = 170 km, nugget = 0.014, range = 1,687 km, partial sill = 0.066.</p

    Multivariable-adjusted odds ratios (AOR) and lower and upper 95% confidence limits (LCL & UCL) for CVD complications from PM<sub>10</sub>-fitted models —assessed with samples from the 2007 and 2009 Behavioral Risk Factor Surveillance System.

    No full text
    <p>Both regionally and non-regionally adjusted results were presented, with the former graphically displayed. BMI and (BMI-squared)/100 were included as continuous variables. PM<sub>10</sub>-related effects were associated with 10 µg/m<sup>3</sup> increment in yearly median levels.</p
    corecore